Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Tenecteplase in the Treatment of Thrombosed Hemodialysis Grafts

Journal Article · · Cardiovascular and Interventional Radiology
 [1];  [2]
  1. Mount Sinai Medical Center, Department of Radiology (United States)
  2. Genentech, Vascular Medicine (United States)
A pilot study was carried out to prospectively evaluate the efficacy and safety of Tenecteplase (TNKase) using a modified 'lyse and wait' technique with percutaneous transluminal angioplasty (PTA) to treat thrombosed hemodialysis arteriovenous grafts (AVG)s. Seven patients with eight hemodialysis AVGs were treated and followed up to 1 year. Dosing included 1 mg TNKase and 3,000-4,000 U of heparin. Technical and clinical success rates were 100% and 88%, respectively. No major complications occurred. Primary patency rates at 30, 90, and 180 days were 62%, 50%, and 33%, respectively. TNKase, used in this fashion, may be comparable to alteplase and reteplase for safe and effective thrombolysis of PTFE dialysis grafts.
OSTI ID:
21091377
Journal Information:
Cardiovascular and Interventional Radiology, Journal Name: Cardiovascular and Interventional Radiology Journal Issue: 4 Vol. 28; ISSN 0174-1551; ISSN CAIRDG
Country of Publication:
United States
Language:
English

Similar Records

Early Detection and Treatment of Hemodialysis Access Dysfunction
Journal Article · Fri Jan 14 23:00:00 EST 2000 · Cardiovascular and Interventional Radiology · OSTI ID:21083680

Mechanical Thrombectomy of Occluded Hemodialysis Native Fistulas and Grafts Using a Hydrodynamic Thrombectomy Catheter: Preliminary Experience
Journal Article · Wed Dec 14 23:00:00 EST 2005 · Cardiovascular and Interventional Radiology · OSTI ID:21091317

Transluminally Placed Endovascular Grafts for Venous Lesions in Patients on Hemodialysis
Journal Article · Fri Aug 15 00:00:00 EDT 2003 · Cardiovascular and Interventional Radiology · OSTI ID:21088371